Health alert after parrot fever that can trigger meningitis infects dozens of humans
Psittacosis, also known as the Parrot Fever, is a respiratory illness that can lead to severe pneumonia and meningitis. (Source: Daily Express - Health)
Source: Daily Express - Health - December 24, 2023 Category: Consumer Health News Source Type: news
When Should We Consider A Rickettsial Disease?
Discussion
Rickettsioses are “small, obligate intracellular, gram-negative, aerobic coccobacillary α-proeobacteria” from the genuses Rickettsia, Anaplasma, Coxiella, Ehrlichia, and Orientia genuses. Often they cause limited health problems but can cause severe disease and death. They present with a fever and other non-specific signs and symptoms, usually with a rash and lymphadenopathy. Other problems can include:
Cardiac – endocarditis, myocarditis, pericarditis
Gastrointestinal – abdominal pain, acute abdomen, cholecystitis, hepatitis, pancreatitis
Heme/Lymph – hemophagocytosis, lymph...
Source: PediatricEducation.org - December 18, 2023 Category: Pediatrics Authors: Pediatric Education Tags: Uncategorized Source Type: news
Why you should NEVER hang on to a lipstick for more than a year if you want to avoid nasty infections, according to skin experts
Dermatologists have claimed that meningitis-causing bacteria can be found on old lipsticks - so advise chucking them after a year. But what about other products in your make up bag? (Source: the Mail online | Health)
Source: the Mail online | Health - December 17, 2023 Category: Consumer Health News Source Type: news
NIH clinical trial of tuberculous meningitis drug regimen begins
Six-month multidrug regimen being evaluated against standard treatment. (Source: National Institutes of Health (NIH) News Releases)
Source: National Institutes of Health (NIH) News Releases - December 7, 2023 Category: American Health Source Type: news
Quick Genetic Test Offers Hope for Sick, Undiagnosed Kids, but Few Insurers Cover It
(MedPage Today) -- Just 48 hours after her birth in a Seattle-area hospital in 2021, Layla Babayev was undergoing surgery for a bowel obstruction.
Two weeks later, she had another emergency surgery, and then developed meningitis. Layla spent more... (Source: MedPage Today Pediatrics)
Source: MedPage Today Pediatrics - October 30, 2023 Category: Pediatrics Source Type: news
Penbraya Vaccine for Meningitis Vaccine May Be On the Way
THURSDAY, Oct. 26, 2023 -- A new vaccine recommended Wednesday by independent advisers to the U.S. Centers for Disease Control and Prevention could provide more comprehensive protection from meningitis. The CDC is weighing the advisers ' ... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - October 26, 2023 Category: Pharmaceuticals Source Type: news
CDC Panel Backs Broader Use of Mpox Vaccine
(MedPage Today) -- The CDC's vaccine advisors on Wednesday endorsed the use of the mpox vaccine for high-risk adults even after the outbreak, along with a newly approved pentavalent meningococcal vaccine for adolescents and younger adults.
Broader... (Source: MedPage Today Infectious Disease)
Source: MedPage Today Infectious Disease - October 26, 2023 Category: Infectious Diseases Source Type: news
Improved Meningitis Vaccine, Penbraya, May Be On the Way
THURSDAY, Oct. 26, 2023 -- A new vaccine recommended Wednesday by independent advisers to the U.S. Centers for Disease Control and Prevention could provide more comprehensive protection from meningitis.
The shot would protect against five types of... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - October 26, 2023 Category: General Medicine Source Type: news
First malaria vaccine slashes early childhood deaths
In a major analysis in Africa, the first vaccine approved to fight malaria cut deaths among young children by 13% over nearly 4 years, the World Health Organization (WHO) reported last week. The huge evaluation of a pilot rollout of the vaccine, called RTS,S or Mosquirix and made by GlaxoSmithKline, also showed a 22% reduction in severe malaria in kids young enough to receive a three-shot series. Hundreds of thousands of children are born annually in the parts of Ghana, Kenya, and Malawi included in the analysis, for which WHO revealed the final data on 20 October at the annual meeting of the American Society of Tropical M...
Source: ScienceNOW - October 24, 2023 Category: Science Source Type: news
FDA Approves Pfizer ’s Vaccine for Meningococcal Disease
The U.S. Food and Drug Administration has approved Pfizer’s application for Penbraya, a vaccine for people 10 through 25 that will offer protection against the five main kinds of bacteria that cause meningitis and blood poisoning. (Source: WebMD Health)
Source: WebMD Health - October 23, 2023 Category: Consumer Health News Source Type: news
New Meningococcal Vaccine Wins FDA Approval New Meningococcal Vaccine Wins FDA Approval
The single shot will cover the five most common serogroups that cause meningococcal disease in children and young adults.Medscape Medical News (Source: Medscape Infectious Diseases Headlines)
Source: Medscape Infectious Diseases Headlines - October 23, 2023 Category: Infectious Diseases Tags: Infectious Diseases News Alert Source Type: news
Misinfo Removal Continues; New Meningitis Vax Approved; Long COVID and Menopause
(MedPage Today) -- Note that some links may require registration or subscription.
The Supreme Court said the Biden administration can temporarily continue to request removal of misleading content, like medical misinformation, from social media... (Source: MedPage Today Public Health)
Source: MedPage Today Public Health - October 23, 2023 Category: American Health Source Type: news
FDA approves PENBRAYA ™, the first and only vaccine for the prevention of the five most common serogroups causing meningococcal disease in adolescents
Pfizer Inc. (NYSE: PFE) announced that the U.S. Food and Drug Administration (FDA) has approved PENBRAYA™ (meningococcal groups A, B, C, W and Y vaccine), the first and only pentavalent vaccine that provides coverage against the most common serogroups causing meningococcal disease in adolescents and young adults 10 through 25 years of age. (Source: World Pharma News)
Source: World Pharma News - October 23, 2023 Category: Pharmaceuticals Tags: Featured Pfizer Business and Industry Source Type: news
FDA Approves Penbraya (meningococcal groups A, B, C, W and Y vaccine) for the Prevention of the Five Most Common Serogroups Causing Meningococcal Disease in Adolescents
NEW YORK--(BUSINESS WIRE) October 20, 2023 -- Pfizer Inc. (NYSE: PFE) announced today that the U.S. Food and Drug Administration (FDA) has approved Penbraya™ (meningococcal groups A, B, C, W and Y vaccine), the first and only pentavalent... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - October 20, 2023 Category: Drugs & Pharmacology Source Type: news
Roche IL-6 is the first immunoassay approved to aid sepsis diagnosis in newborns
Neonatal sepsis is a leading cause of death for newbornsTesting IL-6 can indicate a neonatal sepsis infection earlier than other biomarkersEarlier diagnosis of neonatal sepsis can lead to improved outcomes and a reduction of long-term complications from sepsisBasel, 18 October 2023 - Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that the Elecsys IL-6 immunoassay has become the first IL-6 test to have a certified claim for use in diagnosis of neonatal sepsis, in countries accepting the CE Mark.*Elecsys IL-6 aids physicians in combating the impact of neonatal sepsis by facilitating an early diagnosis. Early and improved...
Source: Roche Investor Update - October 18, 2023 Category: Pharmaceuticals Source Type: news
